Crinetics Pharmaceuticals
CRNX
CRNX
116 hedge funds and large institutions have $995M invested in Crinetics Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 43 increasing their positions, 39 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
21% less capital invested
Capital invested by funds: $1.26B → $995M (-$261M)
44% less funds holding in top 10
Funds holding in top 10: 9 → 5 (-4)
67% less call options, than puts
Call options by funds: $2K | Put options by funds: $6K
Holders
116
Holding in Top 10
5
Calls
$2K
Puts
$6K
Top Buyers
| 1 | +$9.33M | |
| 2 | +$8.79M | |
| 3 | +$6.8M | |
| 4 |
Millennium Management
New York
|
+$4.46M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$4.39M |
Top Sellers
| 1 | -$39.3M | |
| 2 | -$8.45M | |
| 3 | -$7.86M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$3.75M |
| 5 |
ACM
Altium Capital Management
New York
|
-$2.79M |